Excellere Partners
http://www.excellerepartners.com/index.htmExcellere Partners is an equity investment firm. The firm partners with middle-market company entrepreneurs and management teams through management buyouts and majority recapitalizations. Excellere uses a research-driven and top down investment strategy while targeting industry niches that benefit from favorable macro-economic and demographic trends. The firm focuses on the life sciences/medical technology, healthcare, business service, building products and service, specialty finance, and energy and utility service industries. Excellere Partners is headquartered in Denver, Colorado.
View Older Stories View More Recent Stories
-
Excellere Partners Pleased to Announce New Additions to the Firm
-
Excellere Partners Announces Promotion
-
WSC & Company Announces Launch of Middle-Market Buyout Strategy
-
Excellere Partners Announces Promotion
-
ParcelShield Appoints Industry Leader Kirk Nilson as New CEO
-
Excellere Partners Announces Promotions
-
Excellere Partners Announces Professional Staff Additions and Promotion
-
GHO Capital Invests in Biocare Medical, A Global Leader in Oncology-focused Diagnostic Reagents and Instrumentation
-
Excellere Partners Announces the Addition of Three New Associates
-
Excellere Partners Raises $875 Million for Its Fourth Fund, Excellere Capital Fund IV LP
-
Excellere Partners Enters into Strategic Alliance Partnership with Geoff Hall, Former CEO and Recognized Leader in Medical Products and Technology
-
The Vistria Group and Excellere Partners Invest in SCA Pharmaceuticals
-
Envision Pharma Group Acquires Two Labs to Advance Its Position as a Global Strategic Partner to Pharma and Create a Unique and Unrivaled Launch Excellence Offering
-
Industry leaders join forces to battle toxic algae, invasive aquatic weeds and phosphorus pollution
-
ParcelShield Holdings, an Excellere Partners Portfolio Company, Welcomes Two New Board Members
-
Excellere Partners Enters into Strategic Alliance Partnership with Amjed Saffarini, a Recognized Leader in Cybersecurity and Risk Management
-
Asif Ahmad appointed CEO of LucidHealth
-
Excellere Portfolio Company, Biocare Medical, Hires Luis de Luzuriaga as CEO
-
Excellere Partners Announces a Strategic Partnership With ParcelShield Holdings
-
AIS Healthcare Acquires Ophthalmology Compounding Pharmacy Hunt Valley PharmaLAB
-
Medlogix announces the addition of John Martucci to their growing Business Development Team!
-
Excellere Portfolio Company, Biocare Medical, Appoints Nicolas Barthelemy as Executive Chairman
-
Speakers announced for M&A Worldwide’s global conference in Toronto connecting Canadian Private Equity with international M&A experts
-
Speakers announced for M&A Worldwide’s global conference in Toronto connecting Canadian Private Equity with international M&A experts
-
Excellere Partners Announces Promotions and Team Addition
-
Excellere Partners Announces Investment in Concord Technologies, a Leading Provider of Healthcare Interoperability and Automation Solutions
-
Leading Medical Apparel Brand Jaanuu Raises $15 Million in Growth Equity Financing
-
Rob Gelb Joins Medlogix® as Executive Vice President of Business Development
-
Consolidated Services Group Looks to the Future with a Powerful New Branding Campaign and Visual Identity
-
Excellere Partners Enters into Strategic Partnership with Robert Muratore, an Innovative Leader in Healthcare Marketing Services and Communications
-
Mike Schrauben Joins Consolidated Services Group as Vice President of Business Development for the Midwest Region
-
Odyssey Investment Partners Acquires TrialCard
-
Nicole Bianchi Joins Consolidated Services Group as Senior Vice President of Medical Bill Review Services
-
Two Labs Marketing Changes Name to Two Labs to Reflect Expanded Suite of Offerings
-
Excellere Partners Announces Investment in Biocare Medical, a Leading Provider of Immunohistochemistry Instrumentation and Reagents
-
Medical Claims Management Provider Consolidated Services Group (CSG) Announces Strategic Investment by Excellere Partners
-
Excellere Partners Announces Its Investment in Two Labs Marketing
-
Excellere Partners Enters into Growth Partnership with Riverside Radiology and Interventional Associates
-
Excellere Partners Announces the Addition of Two Deal Professionals
-
Excellere Announces Partnership with Proven Behavioral Health Executive Martin Favis
-
Excellere Partners Hires Michael Geldart as Partner
-
Excellere Partners Promotes Brad Cornell and Ryan Glaws to Partner
-
Excellere Partners and TrialCard Win ACG Raleigh’s Deal of the Year Award
-
MTS Medication Tech. (MTSI) and Excellere Partners Complete Merger
-
MTS Medication Tech (MTSI) Stockholders Approve Merger Agreement
-
Notable Mergers and Acquisitions of the Day 8/10: MSFT, MIL, MTSI, WEBM
-
MTS Medication (MTSI) Agrees To Be Acquired For $5.75/Share

